Insurance underwriting in the genetic era

Cancer

Volumn 80, Issue 3 SUPPL., 1997, Pages 587-599

  Pokorski, Robert J ^a  

^a Cologne Life Reinsurance Co ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; INSURANCE; MEDICAL RECORD; PATIENT INFORMATION; PRIORITY JOURNAL;

EID: 0030791605     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19970801)80:3+<587::aid-cncr8>3.0.co;2-6     Document Type: Conference Paper

References (72)

1. Ostrer H, Allen W, Crandall LA, Moseley RE, Dewar MA, Nye D, et al. Insurance and genetic testing: Where are we now? Am J Hum Genet 1993;52:565-7.
2. The American Society of Human Genetics Ad Hoc Committee on Insurance Issues in Genetic Testing. Background statement: genetic testing and insurance. Am J Hum Genet 1995;56:327-31.
3. McGill DM, Holmes JS, Winberg JF. Selection and classification of risks (Part I). In: Graves EE, Hayes L, editors. McGill's Life Insurance. Bryn Mawr, PA: The American College, 1994:435-51.
4. American Council of Life Insurance. 1994 Life Insurance Fact Book. Washington, DC, 1994.
5. Beam BT. Group life insurance. In: Graves EE, Hayes L, editors. McGill's Life Insurance. Bryn Mawr, PA: The American College, 1994:687-733.
6. Koco L. Critical illness policies are selling well in UK. National Underwriter April 29, 1996:21.
7. Society of Actuaries. Mortality under substandard ordinary insurance issues between 1972 and 1977 anniversaries: 1979 reports of mortality and morbidity experience. Transactions 1979:51-61.
8. Swiss Reinsurance Company. Life underwriting at Swiss Re: mortality experience for the years 1963-1987. Zurich, 1994.
9. Geller LN, Alper JS, Billings PR, Barash CI, Beckwith J, Natowicz MR. Individual, family, and societal dimensions of genetic descrimination: a case study analysis. Science and Engineering Ethics 1996;2:71-88.
10. Masood E. Gene tests: Who benefits from risk? Nature 1996;379:389-92.
11. Mehlman MJ, Kodish ED, Whitehouse P, Zinn AB, Sollitto S, Berger J, et al. The need for anonymous genetic counseling and testing. Am J Hun Genet 1996;58:393-7.
12. National Center for Human Genome Research. Genetic information and health insurance: report of the task force on genetic information and insurance. NIH Publication No. 93-3686. Bethesda, MD: National Institutes of Health, 1993.
13. McGill DM, Graves EE. Basic principles. In: Graves EE, Hayes L, editors. McGill's Life Insurance. Bryn Mawr, PA: The American College, 1994:19-31.
14. Maclean JB. Life insurance. New York; McGraw-Hill, 1939:531.
15. Society of Actuaries. Actuarial standard of practice #12 concerning risk classification, Section 2.1, 1989:1.
16. Trowbridge CL. Fundamental concepts of actuarial science. Actuarial Education and Research Fund 1989:53.
17. American Academy of Actuaries. 1980 Journal 1980:6:138-9.
18. Berkshire Life. Where there's smoke, there's fire. Afield May 1993:9.
19. Treaster JB. When the agent of change is a click of the mouse. The New York Times September 6, 1996:D1.
20. Home Office Reference Laboratory. Insight 1994;8:10-11.
21. Becker DN. Pricing for profitability in ART. Best's Review September 1984:26.
22. Pilgrim JW. Mortality experience and underwriting standards. Paper presented at the 1990 annual meeting of the Society of Actuaries, Orlando, Florida, October 17, 1990.
23. Society of Actuaries. 1975-80 15-year select and ultimate basic insurance tables: 1982 reports of mortality and morbidity experience. Transactions 1982:55-81.
24. Internet QuickQuote. http://www.quickquote.com/. March 4, 1996.
25. Huber P. Underwriting genes. Forbes September 28,1992:46.
26. Gross JD. Letter to the editor. Science 1995;270:1282-3.
27. Maddox J. The case for human genome. Nature 1991;352:11-4.
28. Editorial. Whose right to genetic knowledge? Nature 1996;379:379.
29. Pokorski R. Genetic information and life insurance. Nature 1995;376:13-4.
30. Ross PE. Is DNA p.c.? Forbes October 9, 1995:118.
31. King RA, Rotter JI, Motulsky AG, editors. The genetic basis of common diseases. New York. Oxford University Press, 1992.
32. Andrews L, Fullarton J, Holtzman N, Motulsky A, editors. Assessing genetic risks: implications for health and social policy. Washington, DC: National Academy Press, 1994.
33. National Center for Human Genome Research. Genetic information and health insurance: report of the task force on genetic information and insurance. NIH Publication No. 93-3686. Bethesda, MD: National Institutes of Health, 1993.
34. Have you had a genet test? Lancet 1996;347:133.
35. Beardsley T. Vital data. Scientific American March 1996:100-5.
36. Skolnick AA. Russian and US researchers develop "biochips" for faster, inexpensive biomedical tests. JAMA 1996;275:581-2.
37. Voelker R. Move over, Harrods. JAMA 1996;275:584.
38. Stephenson J. Pathologists enter debate on consent for genetic research on stored tissue. JAMA 1996;275:503-4.
39. Lerman C, Croyle RT. Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology 1996;10:191-9.
40. Peshkin BN. The Peters/Stopfer article reviewed. Oncology 1996;10:176-82.
41. Nelson NJ. Caution guides genetic testing for hereditary cancer genes. J Natl Cancer Inst 1996:88:70-2.
42. Earley CL, Strong LC. Certificates of confidentiality: a valuable tool for protecting genetic data. Am J Hum Genet 1995;57:727-31.
43. Medical World News, January 1991:34ff.
44. Rand TG. Advances in genetics will add to primary care physicians' role. ACP Observer April 1993:12.
45. Alliance of Genetic Support Groups. Informed consent: participation in genetic research studies, 1994.
46. Cotton P. Prognosis, diagnosis, or who knows? Time to learn what gene tests mean. JAMA 1995;273:93-5.
47. Perera FP.Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996;88:496-509.
48. Levine AJ. The genetic origins of neoplasia. JAMA 1995;273-592.
49. Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 1996;78:10-6.
50. Abati A, Liotta LA. Looking forward in diagnostic pathology. Cancer 1996;78:1-3.
51. Norton EC, Newhouse JP. Policy options for public long-term care insurance. JAMA 1994;271:1520-4.
52. Post SG. Alzheimer's disease: ethics and progression of dementia. Clin Geriatr Med 1994;10:379-94.
53. lost BC, Grossberg GT. the natural history of Alzheimer's disease: a brain bank study. J Am Geriatr Soc 1995;43:1248-55.
54. Hyman BT, Tanzi R. Molecular epidemiology of Alzheimer's disease. N Engl J Med 1995;333:1283-4.
55. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, et al. Apolopoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-7.
56. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer Disease. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 1995;274:1627-9.
57. Gilbert S. Alzheimer's group finds many members want test for risk. The New York Times December 13, 1995:C13.
58. National Institute on Aging/Alzheimer's Association Working Group. Consensus statement: apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996;347:1091-5.
59. Sherrington R, Rogaev EI, Liang Y, rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60.
60. Barinaga M. New Alzheimer's gene found. Science 1995;268:1845-6.
61. 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 1996;44:133-8.
62. Blass JP. Age-associated memory impairment and Alzheimer's disease. J Am Geriatr Soc 1996;44:209-11.
63. Murtaugh CM, Kemper P, Spillman BC. Risky business: long-term care insurance underwriting. Inquiry 1995;32:271-84.
64. Dixon ME, Graber M, Perlman B. Monitoring attitudes of the public. Washington, DC: American Council of Life Insurance, 1995.
65. Coronel S, Fulton D. Long-term care insurance in 1993. Washington, DC: Health Insurance Association of America, 1995.
66. U.S. Department of Labor, Bureau of Labor Statistics. Employee benefits in medium and large private establishments, 1993. Washington, DC: U.S. Government Printing Office, 1995.
67. Quint M. New ailments: bane of insurers. The New York Times November 28, 1994:DI.
68. Adelsberger B. SGLI plan would widen. Air Force Times February 12, 1996.
69. Your 1995 Financial Planning Guide. Alexandria, VA: Financial Services Publishing Company, 1995:37.
70. Myers RJ. Summary of the provisions of the old-age, survivors, and disability insurance system, January 1996:1-29.
71. 1995 Annual Report of the Board of Trustees of the Federal Old-Age and Survivors Insurance and Disability Insurance Trust Funds. Washington DC: U.S. Government Printing Office, April 1995:53.
72. American Council of Life Insurance. 1995 Life Insurance Fact Book Update. Washington, DC, 1995.